Monitoring Oncology Clinical Trials April 2011

Course Description 

This course will provide attendees with a general overview of oncology clinical trials and their distinct characteristics. We will review how oncology clinical trials differ from those in other therapeutic areas, with a special emphasis on the unique challenges of monitoring oncology clinical trials. Distinctions will be drawn between early and later phase trials. Attention will be paid to adverse event and serious adverse event reporting in oncology clinical trials. Discuss all aspects of oncology clinical trials and how to successfully monitor them. 


Learning Objectives 

  • Identify the differences between monitoring oncology early phase clinical trials vs. later phase clinical trials
  • Identify ways in which oncology clinical trials differ from those in other therapeutic areas
  • Describe the complexities of AE and SAE monitoring in oncology clinical trials
  • Utilize Common Terminology Criteria for Adverse Events (CTCAE) grading and apply CTCAE to AE source data
  • Address common challenges in monitoring and apply tools and techniques to overcome them

Who Should Attend 

  • Monitors who are new to or are interested in learning more about oncology clinical trials


Jacqueline Earabino, R.N., B.S.N.

Click here for complete trainer biographies 

Course Length Time 

2 hours; 1:00 - 3:00 p.m. Eastern

Course Dates 

April 4, 2011

Hold this course at your company! 
For more information, contact Naila Ganatra at (215) 413-2471